{"created":"2023-05-15T10:25:34.799702+00:00","id":20624,"links":{},"metadata":{"_buckets":{"deposit":"d131fc30-fdcb-472f-9179-420fdef2e133"},"_deposit":{"created_by":1,"id":"20624","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"20624"},"status":"published"},"_oai":{"id":"oai:u-fukui.repo.nii.ac.jp:00020624","sets":["2392:2393"]},"author_link":["59650","59651","59656","59652","59654","59655","59653"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2007-03","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"766","bibliographicPageStart":"764","bibliographicVolumeNumber":"104","bibliographic_titles":[{"bibliographic_title":"Gynecologic oncology"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Background. The positron emission tomography (PET) with F18 17β-estradiol (FES) has good imaging for assessment of estrogen receptor in breast cancer. Case. We report on a 30-year-old woman who desired to preserve her fertility with well-differentiated endometrial adenocarcinoma. Before hormone treatment was started, FES-PET showed increased uptake of endometrium, magnetic resonance imaging (MRI) showed thickness and F- 18 fluorodeoxyglucose (FDG)-PET showed increased uptake. FES-PET after 3 months showed remaining FES uptake, but there were no abnormal findings on MRI and FDG-PET. Hysteroscopy showed remaining adenocarcinoma. After additional treatment, FES-PET showed a therapeutic response, and hysteroscopy showed no abnormal finding. Conclusions. To our knowledge, this is the first report that FES-PET has the potential to provide more useful information than did FDG-PET about the hormone therapy.","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier"}]},"item_10001_relation_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"TD00006319","subitem_relation_type_select":"NCID"}}]},"item_10001_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1016/j.ygyno.2006.10.024","subitem_relation_type_select":"DOI"}}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"908258","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_b1a7d7d4d402bcce","subitem_version_type":"AO"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"YOSHIDA, Yoshio"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"KUROKAWA, Tetsuji"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"SAWAMURA, Yoko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"SHINAGAWA, Akiko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"OKAZAWA, Hidehiko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"FUJIBAYASHI, Yasuhisa"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"KOTSUJI, Fumikazu"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-08-04"}],"displaytype":"detail","filename":"article.pdf","filesize":[{"value":"582.8 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"article.pdf","url":"https://u-fukui.repo.nii.ac.jp/record/20624/files/article.pdf"},"version_id":"dfa94cd6-3957-430e-a767-ba4ccca62c02"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"FES-PET","subitem_subject_scheme":"Other"},{"subitem_subject":"Endometrial cancer","subitem_subject_scheme":"Other"},{"subitem_subject":"Endocrine treatment","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer"}]},"item_type_id":"10001","owner":"1","path":["2393"],"pubdate":{"attribute_name":"公開日","attribute_value":"2008-12-17"},"publish_date":"2008-12-17","publish_status":"0","recid":"20624","relation_version_is_last":true,"title":["The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T13:35:21.455068+00:00"}